Drug intelligence / Profile preview

Q-VIT Plus

Development stage: Unknown
Lead developer: Niner Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

Q-VIT Plus is a combination antioxidant and multivitamin product marketed by Niner Pharmaceuticals. It is formulated as a branded generic pharmaceutical, typically containing a blend of Coenzyme Q10, Lycopene, L-Carnitine, and essential trace elements such as Zinc and Selenium. The product is intended to address micronutrient deficiencies and reduce oxidative stress, which is implicated in various chronic conditions and male infertility. As a finished pharmaceutical product, it is distributed for oral administration to support cellular energy metabolism and provide systemic antioxidant protection.

Brand names: Q-VIT Plus
Other names: Q-VIT Plus

Targets

OXPHOS (Mitochondrial OXPHOS complexes)SELENOS (Selenoprotein S)SLC25A20 (Carnitine/acylcarnitine translocase)

Beyond the preview

Go deeper on Q-VIT Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Q-VIT Plus.

Explore the full profile